TSX-V:NPTH • CA64133P1009
The current stock price of NPTH.CA is 0.44 CAD. In the past month the price decreased by -12.87%. In the past year, price increased by 120%.
ChartMill assigns a technical rating of 7 / 10 to NPTH.CA. When comparing the yearly performance of all stocks, NPTH.CA is one of the better performing stocks in the market, outperforming 81.13% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA. While NPTH.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months NPTH.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 34.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.2% | ||
| ROE | -2.63% | ||
| Debt/Equity | 0.56 |
5 analysts have analysed NPTH.CA and the average price target is 0.51 CAD. This implies a price increase of 15.91% is expected in the next year compared to the current price of 0.44.
For the next year, analysts expect an EPS growth of 100% and a revenue growth 22.77% for NPTH.CA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB | WELL HEALTH TECHNOLOGIES | 238.51 | 25.272B | ||
| WELL | WELL HEALTH TECHNOLOGIES COR | 9.49 | 1.006B | ||
| AIDX | HEALWELL AI INC | N/A | 184.792M | ||
| NLH | NOVA LEAP HEALTH CORP | N/A | 27.939M |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
NeuPath Health, Inc. operates as a healthcare services company that provides chronic pain management services. The company is headquartered in Mississauga, Ontario and currently employs 148 full-time employees. The company went IPO on 2019-12-03. The company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical companies. The firm's health care providers cover a range of specialties and include physiatrists, neurologists, anesthesiologists, orthopedic surgeons, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, among others.
NEUPATH HEALTH INC
110 - 110 Matheson Blvd West
Mississauga ONTARIO L5N 3E7 CA
CEO: Grant Connelly
Employees: 148
Phone: 18002653429
NeuPath Health, Inc. operates as a healthcare services company that provides chronic pain management services. The company is headquartered in Mississauga, Ontario and currently employs 148 full-time employees. The company went IPO on 2019-12-03. The company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical companies. The firm's health care providers cover a range of specialties and include physiatrists, neurologists, anesthesiologists, orthopedic surgeons, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, among others.
The current stock price of NPTH.CA is 0.44 CAD. The price increased by 2.33% in the last trading session.
NPTH.CA does not pay a dividend.
NPTH.CA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
5 analysts have analysed NPTH.CA and the average price target is 0.51 CAD. This implies a price increase of 15.91% is expected in the next year compared to the current price of 0.44.
NEUPATH HEALTH INC (NPTH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).